Covid-19 impact on blood cancer patients receiving stem cell transplants
A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react…
cancer
Life saving ‘pre-hab’ service for lung cancer patients
Consultants at Barts Health have trialled a potentially lifesaving 'pre-hab' programme to help patients become physically fit so that they…
APPG RT responds to NHS England’s comments
The All-Party Parliamentary Group for Radiotherapy APPG RT responds to NHS England's comments at the Health and Social Care Committee.…
Covid-19: deaths from cancer could rise by at least 20%
Bowel Cancer UK have commented that Deaths in people with cancer could rise by at least 20%. The COVID-19 emergency…
MPs demand urgent action on PPE & radiotherapy capacity
MPs have today written to the Secretary of State for Health & Social Care urging him to prioritise the supply…
First Comprehensive Survey of Virus DNA Found Within Cancer Cells
Researchers from the University of East Anglia have helped to carry out the first comprehensive survey of viruses found within…
Calls For Flexibility To All ‘Game Changing’ Cancer Treatments
Sarcoma UK is calling on the National Institute for Health and Care Excellence (NICE), NHS England, and pharmaceutical companies to…
Cancers Engaged in Evolutionary Arms Race with Immune System
- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system - Findings underline importance of…
Cancer Research Offers More Hope Than People Think
· Only 28 per cent of people believe cancers can be controlled long term – yet the average patient now…
Life Extending Cancer Drug will not be made Available to all Patients in Scotland
Sarcoma UK is disappointed to see that life extending cancer drug trabectedin (Yondelis) will not be made available routinely on…
Queen’s University Belfast Awarded Research Grant to Improve Bone Marrow Cancer Treatment
Researchers at Queen’s University Belfast have received the first scientific research grant from MDS UK to improve treatment for Myelodysplastic…
Immunotherapy Backed as Standard First-line Treatment for Head and Neck Cancer
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy…